다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
BMC infectious diseases, v.22 = v.22 no.1, 2022년, pp.149 -
Parmar, Heta (The Public Health Research Institute and the Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ USA) , Montovano, Margaret (School of Medicine, Rutgers New Jersey Medical School, Newark, NJ USA) , Banada, Padmapriya (The Public Health Research Institute and the Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ USA) , Pentakota, Sri Ram (The Public Health Research Institute and the Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ USA) , Shiau, Stephanie (Department of Biostatistics & Epidemiology, Rutgers School of Public Health, Piscataway, NJ USA) , Ma, Zhongjie (Department of Biostatistics & Epidemiology, Rutgers School of Public Health, Piscataway, NJ USA) , Saibire, Kaheerman (The Public Health Research Institute and the Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ USA) , Chopoorian, Abby (The Public Health Research Institute and the Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ USA) , O’Shaughnessy, Michael (School of Medicine, Rutgers New Jersey Medical School, Newark, NJ USA) , Hirsch, Mitchell (School of Medicine, Rutgers New Jersey Medical School,) , Jain, Priyanshi , Demirdjian, Gaiane , Karagueuzian, Magali , Robin, Thomas , Salvati, Michael , Patel, Bhavana , Alland, David , Xie, Yingda L.
AI-Helper
BackgroundCOVID-19 is a multi-system infection with emerging evidence-based antiviral and anti-inflammatory therapies to improve disease prognosis. However, a subset of patients with COVID-19 signs and symptoms have repeatedly negative RT-PCR tests, leading to treatment hesitancy. We used comparativ...
1. Chen N Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Lancet 2020 395 10223 507 513 10.1016/S0140-6736(20)30211-7 32007143
2. Huang C Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet 2020 395 10223 497 506 10.1016/S0140-6736(20)30183-5 31986264
3. Wang D Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China JAMA 2020 10.1001/jama.2020.1585 33201198
4. In Vitro Diagnostics EUAs—Molecular Diagnostic Tests for SARS-CoV-2 https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-molecular-diagnostic-tests-sars-cov-2 .
5. Banada P Sample collection and transport strategies to enhance yield, accessibility, and biosafety of COVID-19 RT-PCR testing J Med Microbiol 2021 10.1099/jmm.0.001380 34486972
6. Payne D Preanalytical issues affecting the diagnosis of COVID-19 J Clin Pathol 2021 74 4 207 208 10.1136/jclinpath-2020-206751 32631944
7. To KK Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study Lancet Infect Dis 2020 20 5 565 574 10.1016/S1473-3099(20)30196-1 32213337
8. Kucirka LM Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure Ann Intern Med 2020 173 4 262 267 10.7326/M20-1495 32422057
9. He X Temporal dynamics in viral shedding and transmissibility of COVID-19 Nat Med 2020 26 5 672 675 10.1038/s41591-020-0869-5 32296168
10. Arevalo-Rodriguez I False-negative results of initial RT-PCR assays for COVID-19: a systematic review PLoS ONE 2020 15 12 e0242958 10.1371/journal.pone.0242958 33301459
11. Bwire GM Detection profile of SARS-CoV-2 using RT-PCR in different types of clinical specimens: a systematic review and meta-analysis J Med Virol 2021 93 2 719 725 10.1002/jmv.26349 32706393
12. Wang W Detection of SARS-CoV-2 in different types of clinical specimens JAMA 2020 323 18 1843 1844 32159775
13. Ng KW Preexisting and de novo humoral immunity to SARS-CoV-2 in humans Science 2020 370 6522 1339 1343 10.1126/science.abe1107 33159009
14. Lisboa Bastos M Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis BMJ 2020 370 m2516 10.1136/bmj.m2516 32611558
15. Centers for Disease Control and Prevention—COVID Data Tracker. https://covid.cdc.gov/covid-data-tracker/#national-lab .
16. Bajema KL Estimated SARS-CoV-2 seroprevalence in the US as of September 2020 JAMA Intern Med 2021 181 4 450 460 10.1001/jamainternmed.2020.7976 33231628
17. WHO COVID-19 Case Definition. https://www.who.int/publications/i/item/WHO-2019-nCoV-Surveillance_Case_Definition-2020.2 .
18. U.S Food and Drug Administration Emergency Use Authorization. In vitro diagnostics EUAs—serology and other adaptive immune response tests for SARS-CoV-2. https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-serology-and-other-adaptive-immune-response-tests-sars-cov-2 .
19. Tan CW A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction Nat Biotechnol 2020 38 9 1073 1078 10.1038/s41587-020-0631-z 32704169
20. Zhao J Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019 Clin Infect Dis 2020 71 16 2027 2034 10.1093/cid/ciaa344 32221519
21. Long QX Antibody responses to SARS-CoV-2 in patients with COVID-19 Nat Med 2020 10.1038/s41591-020-0897-1 33020648
22. Zhang Z Insight into the practical performance of RT-PCR testing for SARS-CoV-2 using serological data: a cohort study Lancet Microbe 2021 2 2 e79 e87 10.1016/S2666-5247(20)30200-7 33495759
23. Kreer C Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients Cell 2020 182 4 843 854 e12 10.1016/j.cell.2020.06.044 32673567
24. Qiang M, et al. Neutralizing antibodies to SARS-CoV-2 selected from a human antibody library constructed decades ago. Adv Sci (Weinh). 2022;9(1):e2102181. 10.1002/advs.202102181.
25. RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffery K, Montgomery A, Rowan K, Juszczak E, Baillie JK, Haynes R, Landray MJ. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021 Feb 25;384(8):693–704. 10.1056/NEJMoa2021436.
26. Olsen SJ Changes in influenza and other respiratory virus activity during the COVID-19 pandemic—United States, 2020–2021 MMWR Morb Mortal Wkly Rep 2021 70 29 1013 1019 10.15585/mmwr.mm7029a1 34292924
27. Middleton P Characteristics and outcomes of clinically diagnosed RT-PCR swab negative COVID-19: a retrospective cohort study Sci Rep 2021 11 1 2455 10.1038/s41598-021-81930-0 33510247
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.